Tsumura & Co. (4540.T)
JPY 4759.0
(-0.69%)
JPY 4759.0
(-0.69%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 30.77 Billion JPY | -10.34% |
| 2022 | 31.52 Billion JPY | -2.69% |
| 2021 | 31.56 Billion JPY | 18.48% |
| 2020 | 27.99 Billion JPY | 13.23% |
| 2019 | 25.28 Billion JPY | 0.24% |
| 2018 | 24.88 Billion JPY | 8.39% |
| 2017 | 23.2 Billion JPY | 9.13% |
| 2016 | 21.61 Billion JPY | -10.36% |
| 2015 | 24.88 Billion JPY | -8.97% |
| 2014 | 24.87 Billion JPY | -6.39% |
| 2013 | 27.33 Billion JPY | 1.57% |
| 2012 | 28.32 Billion JPY | 10.48% |
| 2011 | 26.53 Billion JPY | 1.68% |
| 2010 | 24.77 Billion JPY | 12.35% |
| 2009 | 22.27 Billion JPY | 10.64% |
| 2008 | 21.78 Billion JPY | 5.72% |
| 2007 | 18.7 Billion JPY | 3.86% |
| 2006 | 25.25 Billion JPY | -5.47% |
| 2005 | 18.96 Billion JPY | 40.38% |
| 2004 | 13.02 Billion JPY | 5.92% |
| 2003 | 13.54 Billion JPY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 13.38 Billion JPY | 265.6% |
| 2023 Q1 | 8.66 Billion JPY | 81.18% |
| 2023 Q4 | 3.66 Billion JPY | -70.94% |
| 2023 FY | - JPY | -10.34% |
| 2023 Q3 | 12.59 Billion JPY | 34.15% |
| 2023 Q2 | 9.38 Billion JPY | 8.36% |
| 2022 Q3 | 8.25 Billion JPY | -17.54% |
| 2022 FY | - JPY | -2.69% |
| 2022 Q1 | 11.27 Billion JPY | 56.01% |
| 2022 Q2 | 10 Billion JPY | -11.23% |
| 2022 Q4 | 4.78 Billion JPY | -42.06% |
| 2021 Q4 | 7.22 Billion JPY | -27.55% |
| 2021 FY | - JPY | 18.48% |
| 2021 Q1 | 9.55 Billion JPY | 90.83% |
| 2021 Q2 | 8.51 Billion JPY | -10.91% |
| 2021 Q3 | 9.97 Billion JPY | 17.2% |
| 2020 Q4 | 5 Billion JPY | -46.25% |
| 2020 Q1 | 7.76 Billion JPY | 64.92% |
| 2020 Q2 | 7.68 Billion JPY | -0.98% |
| 2020 Q3 | 9.31 Billion JPY | 21.2% |
| 2020 FY | - JPY | 13.23% |
| 2019 Q3 | 8.42 Billion JPY | 38.19% |
| 2019 FY | - JPY | 0.24% |
| 2019 Q1 | 7.06 Billion JPY | 34.27% |
| 2019 Q2 | 6.09 Billion JPY | -13.78% |
| 2019 Q4 | 4.7 Billion JPY | -44.12% |
| 2018 Q2 | 6.27 Billion JPY | -3.85% |
| 2018 Q3 | 8.16 Billion JPY | 30.11% |
| 2018 Q4 | 5.26 Billion JPY | -35.51% |
| 2018 Q1 | 6.52 Billion JPY | 72.3% |
| 2018 FY | - JPY | 8.39% |
| 2017 Q3 | 8.04 Billion JPY | 28.75% |
| 2017 Q2 | 6.24 Billion JPY | 2.04% |
| 2017 Q4 | 3.78 Billion JPY | -52.91% |
| 2017 Q1 | 6.12 Billion JPY | 79.82% |
| 2017 FY | - JPY | 9.13% |
| 2016 FY | - JPY | -10.36% |
| 2016 Q2 | 4.53 Billion JPY | -17.32% |
| 2016 Q3 | 8.73 Billion JPY | 92.51% |
| 2016 Q4 | 3.4 Billion JPY | -61.04% |
| 2016 Q1 | 5.49 Billion JPY | 21.06% |
| 2015 FY | - JPY | -8.97% |
| 2015 Q4 | 4.53 Billion JPY | -39.52% |
| 2015 Q2 | 6.27 Billion JPY | -2.37% |
| 2015 Q3 | 7.49 Billion JPY | 19.51% |
| 2015 Q1 | 6.42 Billion JPY | 17.63% |
| 2014 Q4 | 5.46 Billion JPY | -44.34% |
| 2014 Q1 | 5.83 Billion JPY | -11.24% |
| 2014 Q2 | 6.05 Billion JPY | 3.73% |
| 2014 FY | - JPY | -6.39% |
| 2014 Q3 | 9.81 Billion JPY | 62.1% |
| 2013 Q4 | 6.57 Billion JPY | -27.78% |
| 2013 FY | - JPY | 1.57% |
| 2013 Q1 | 7.08 Billion JPY | 13.77% |
| 2013 Q2 | 6.26 Billion JPY | -11.61% |
| 2013 Q3 | 9.1 Billion JPY | 45.46% |
| 2012 Q1 | 7.1 Billion JPY | 36.66% |
| 2012 Q4 | 6.22 Billion JPY | -33.04% |
| 2012 Q2 | 5.95 Billion JPY | -16.21% |
| 2012 Q3 | 9.29 Billion JPY | 56.21% |
| 2012 FY | - JPY | 10.48% |
| 2011 Q4 | 5.19 Billion JPY | -40.86% |
| 2011 FY | - JPY | 1.68% |
| 2011 Q1 | 7.07 Billion JPY | 14.53% |
| 2011 Q3 | 8.78 Billion JPY | 83.05% |
| 2011 Q2 | 4.8 Billion JPY | -32.16% |
| 2010 Q1 | 6.19 Billion JPY | 45.4% |
| 2010 Q3 | 7.59 Billion JPY | 38.71% |
| 2010 Q4 | 6.17 Billion JPY | -18.59% |
| 2010 FY | - JPY | 12.35% |
| 2010 Q2 | 5.47 Billion JPY | -11.61% |
| 2009 FY | - JPY | 10.64% |
| 2009 Q4 | 4.25 Billion JPY | -45.06% |
| 2009 Q3 | 7.75 Billion JPY | 50.43% |
| 2009 Q2 | 5.15 Billion JPY | -5.93% |
| 2009 Q1 | 5.47 Billion JPY | 25.13% |
| 2008 Q4 | 4.37 Billion JPY | -31.49% |
| 2008 Q2 | 3.61 Billion JPY | 0.0% |
| 2008 FY | - JPY | 5.72% |
| 2008 Q3 | 6.38 Billion JPY | 76.54% |
| 2007 FY | - JPY | 3.86% |
| 2006 FY | - JPY | -5.47% |
| 2005 FY | - JPY | 40.38% |
| 2004 FY | - JPY | 5.92% |
| 2003 FY | - JPY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 6.02 Billion JPY | -411.078% |
| Takeda Pharmaceutical Company Limited | 874.6 Billion JPY | 96.482% |
| Sumitomo Pharma Co., Ltd. | -281.07 Billion JPY | 110.948% |
| Shionogi & Co., Ltd. | 186.7 Billion JPY | 83.518% |
| Wakamoto Pharmaceutical Co.,Ltd. | 570.97 Million JPY | -5289.406% |
| Nippon Shinyaku Co., Ltd. | 36.29 Billion JPY | 15.205% |
| Kaken Pharmaceutical Co., Ltd. | 12.26 Billion JPY | -150.852% |
| Eisai Co., Ltd. | 103.1 Billion JPY | 70.155% |
| Morishita Jintan Co., Ltd. | 1.29 Billion JPY | -2279.892% |
| Hisamitsu Pharmaceutical Co., Inc. | 18.34 Billion JPY | -67.786% |
| Mochida Pharmaceutical Co., Ltd. | 8.97 Billion JPY | -242.94% |
| Fuso Pharmaceutical Industries,Ltd. | 3.67 Billion JPY | -738.474% |
| Nippon Chemiphar Co., Ltd. | 1.4 Billion JPY | -2093.3% |
| Kissei Pharmaceutical Co., Ltd. | 18.72 Billion JPY | -64.38% |
| Torii Pharmaceutical Co., Ltd. | 5.27 Billion JPY | -483.798% |
| Towa Pharmaceutical Co., Ltd. | 35.53 Billion JPY | 13.406% |
| Fuji Pharma Co., Ltd. | 6.88 Billion JPY | -347.137% |
| Zeria Pharmaceutical Co., Ltd. | 17.52 Billion JPY | -75.623% |
| KYORIN Holdings, Inc. | 10.29 Billion JPY | -198.873% |
| Taiko Pharmaceutical Co.,Ltd. | -3.75 Billion JPY | 920.587% |
| Daito Pharmaceutical Co.,Ltd. | 7.55 Billion JPY | -307.414% |
| SymBio Pharmaceuticals Limited | -714 Million JPY | 4409.804% |
| MedRx Co., Ltd | -884.51 Million JPY | 3578.965% |
| Mizuho Medy Co.,Ltd. | 5.53 Billion JPY | -455.823% |
| Solasia Pharma K.K. | -635 Million JPY | 4945.984% |
| Modalis Therapeutics Corporation | -2.37 Billion JPY | 1396.251% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 9.16 Billion JPY | -235.829% |
| Sawai Group Holdings Co., Ltd. | 36.87 Billion JPY | 16.546% |
| Cyfuse Biomedical K.K. | -538.28 Million JPY | 5816.632% |
| Toho Holdings Co., Ltd. | 25.84 Billion JPY | -19.064% |
| Koa Shoji Holdings Co.,Ltd. | 5.1 Billion JPY | -503.178% |